Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Biochemical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-2952(90)90153-cPMID 2154993
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies on the interaction of 4-quinolones with DNA by DNA unwinding experiments.

  1988cited by this paper
• Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells.

  1988cited by this paper
• Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme.

  1987cited by this paper
• DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators.

  1987cited by this paper
• Genistein, a specific inhibitor of tyrosine-specific protein kinases.

  1987cited by this paper
• Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II.

  1986cited by this paper
• A specific inhibitor for tyrosine protein kinase from Pseudomonas.

  1986cited by this paper
• The metabolism of flavonoid compounds in mammals.

  1986cited by this paper
• DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II.

  1986cited by this paper
• Purification and characterization of a type II DNA topoisomerase from bovine calf thymus.

  1985cited by this paper
• DNA topoisomerases as targets for cancer therapy.

  1985cited by this paper
• DNA topoisomerases.

  1985cited by this paper
• Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.

  1984cited by this paper
• Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II.

  1984cited by this paper
• Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.

  1984cited by this paper
• Calcium and phospholipid-dependent protein kinase activity in mouse epidermis cytosol. Stimulation by complete and incomplete tumor promoters and inhibition by various compounds.

  1984cited by this paper
• Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

  1984cited by this paper
• The effect of quercetin on the phosphorylation activity of the Rous sarcoma virus transforming gene product in vitro and in vivo.

  1983cited by this paper
• Cleavage of DNA by mammalian DNA topoisomerase II.

  1983cited by this paper
• Quercetin interaction with the (Ca2+ + Mg2+)-ATPase of sarcoplasmic reticulum.

  1981cited by this paper
• A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds.

  1980cited by this paper
• Antineoplastic activity and cytotoxicity of flavones, isoflavones, and flavanones.

  1979cited by this paper
• Mutagenic activity of quercetin and related compounds.

  1977cited by this paper
• The flavonoids. A class of semi-essential food components: their role in human nutrition.

  1976cited by this paper
• The effect of flavonoids on aerobic glycolysis and growth of tumor cells.

  1975cited by this paper
• Effects of quercetin and F1 inhibitor on mitochondrial ATPase and energy-linked reactions in submitochondrial particles.

  1974cited by this paper

• Therapeutic Potential of Quercetin-Loaded Nanoemulsion against Experimental Visceral Leishmaniasis: In Vitro/Ex Vivo Studies and Mechanistic Insights.

  2022cites this paper
• Cancer incidence and survival trends among infants in the United States from 1975 to 2014

  2020cites this paper
• Flavonoids as potential therapeutic agents for the management of diabetic neuropathy.

  2020cites this paper
• Cytotoxic Effects of Moringa oleifera Leaf Extract on Human Hepatoma Cell Line HepG-2

  2020cites this paper
• Scavenging of hydroxyl, methoxy, and nitrogen dioxide free radicals by some methylated isoflavones

  2018cites this paper
• Analysis of Fluorescence Spectra of Citrus Polymethoxylated Flavones and Their Incorporation into Mammalian Cells.

  2018cites this paper
• Scaffold-hopping of bioactive flavonoids: Discovery of aryl-pyridopyrimidinones as potent anticancer agents that inhibit catalytic role of topoisomerase IIα.

  2016cites this paper
• Colloidal gold-based indirect competitive immunochromatographic assay for rapid detection of bioactive isoflavone glycosides daidzin and genistin in soy products.

  2016cites this paper
• Genistein as antioxidant and antibrowning agents in in vivo and in vitro: A review.

  2016cites this paper
• Genistein potentiates the effect of 17-beta estradiol on human hepatocellular carcinoma cell line

  2016cites this paper
• Pure erythroid leukemia in four month old infant – case report

  2016cites this paper
• A REVIEW ON GLYCINE MAX (L.) MERR. (SOYBEAN)

  2015cites this paper
• Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors.

  2015cites this paper
• The effects of dietary soybean isoflavones on growth, innate immune responses, hepatic antioxidant abilities and disease resistance of juvenile golden pompano Trachinotus ovatus.

  2015cites this paper
• Plant-Based and Plant-Rich Diet Patterns during Gestation: Beneficial Effects and Possible Shortcomings.

  2015cites this paper
• Effects of dietary soybean isoflavones on non-specific immune responses and hepatic antioxidant abilities and mRNA expression of two heat shock proteins (HSPs) in juvenile golden pompano Trachinotus ovatus under pH stress.

  2015cites this paper
• Therapeutic options for management of endometrial hyperplasia

  2015cites this paper
• A possible cause of Alzheimer's dementia - industrial soy foods.

  2014cites this paper
• Obesity - a natural consequence of human evolution

  2014cites this paper
• Integrating Traditional Medicine into Modern Inflammatory Diseases Care: Multitargeting by Rhus verniciflua Stokes

  2014cites this paper
• Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells

  2014cites this paper
• Proteolytic Degradation of Topoisomerase II (Top2) Enables the Processing of Top2·DNA and Top2·RNA Covalent Complexes by Tyrosyl-DNA-Phosphodiesterase 2 (TDP2)* ♦

  2014cites this paper
• Modulation of radiation-induced and mitomycin C-induced chromosome damage by apigenin in human lymphocytes in vitro

  2013cites this paper
• The Role of ERK5 in Cell Proliferation

  2013cites this paper
• Behavioral, morphological and histopathological effects of sublethal doses of quercetin on the species Polycelis felina (Dalyell).

  2013cites this paper
• Prediction of noncovalent Drug/DNA interaction using computational docking models: Studies with over 1350 launched drugs

  2013cites this paper
• Flavonoid dimers as novel, potent antileishmanial agents.

  2012cites this paper
• Antipromastigotes Activity of Synthetic Flavonoid Dimers with PEG Linkers

  2012cites this paper
• Antimicrobial and antiurease activities of newly synthesized morpholine derivatives containing an azole nucleus

  2012cites this paper
• Cyclin-dependent kinase inhibition by flavoalkaloids.

  2012cites this paper
• Isoflavones: estrogenic activity, biological effect and bioavailability

  2012cites this paper
• Estradiol and Genistein Alter Cellular Physiology of Non-Malignant Colonocytes

  2012cites this paper
• Synthesis, biological assay in vitro and molecular docking studies of new Schiff base derivatives as potential urease inhibitors.

  2011cites this paper
• Fragments of microcin B17 as a source of new topoisomerase inhibitors

  2010cites this paper
• The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.

  2010cites this paper
• Genistein directly inhibits native and recombinant NMDA receptors.

  2010cites this paper
• A-ring ortho-specific monohydroxylation of daidzein by cytochrome P450s of Nocardia farcinica IFM10152.

  2009cites this paper
• 2'-hydroxylation of genistein enhanced antioxidant and antiproliferative activities in mcf-7 human breast cancer cells.

  2009cites this paper
• Estrogen treatment induces MLL aberrations in human lymphoblastoid cells.

  2009cites this paper
• Influence of red clover (Trifolium pratense) isoflavones on gene and protein expression profiles in liver of ovariectomized rats.

  2009cites this paper
• Delphinidin modulates the DNA-damaging properties of topoisomerase II poisons.

  2009cites this paper
• nfant AML : The Highest Incidence n Infants

  2008cites this paper
• Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study.

  2008cites this paper
• Phytoestrogens and breast cancer: a complex story

  2008cites this paper
• Quantitative Determination of Isoflavones in Soy Based Nutritional Supplements by High-Performance Liquid Chromatography

  2008cites this paper
• Flavonoids as RTK inhibitors and potential anticancer agents

  2008cites this paper
• Environmental and genetic susceptibility to MLL-defined infant leukemia.

  2008cites this paper
• Cancer Chemoprevention Through Dietary Antioxidants: Progress and Promise

  2008cites this paper
• The ABCs of infant leukemia.

  2008cites this paper
• C-Terminal regions of topoisomerase IIα and IIβ determine isoform-specific functioning of the enzymes in vivo

  2007cites this paper
• Dietary flavonoids induce MLL translocations in primary human CD34+ cells.

  2007cites this paper
• Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.

  2007cites this paper
• Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not.

  2007cites this paper
• Assessment of chromosomal genotoxicity of steroidal hormones related to drug development

  2007cites this paper
• Phytoestrogens: perpetrators or protectors?

  2007cites this paper
• Effects of a high daily dose of soy isoflavones on DNA damage, apoptosis and estrogenic outcomes in healthy, post‐menopausal women ‐ a Phase I clinical trial

  2007cites this paper
• Effects of the soy phytoestrogen genistein on the reproductive development of immature female broiler chickens

  2007cites this paper
• Cells lacking DNA topoisomerase II beta are resistant to genistein.

  2007cites this paper
• Polyphenols based on isoflavones as inhibitors of Helicobacter pylori urease.

  2007cites this paper
• Bioavailability of genistein and its glycoside genistin

  2006cites this paper
• CYP1A1 activation of aminoflavone leads to DNA damage in human tumor cell lines

  2006cites this paper
• Evaluation of apigenin using in vitro cytochalasin blocked micronucleus assay.

  2006cites this paper
• Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin.

  2006cites this paper
• Leishmania donovani: intracellular ATP level regulates apoptosis-like death in luteolin induced dyskinetoplastid cells.

  2006cites this paper
• Effects of genistein on angiotensin-converting enzyme in rats.

  2006cites this paper
• Soy isoflavones and bone health: a double-edged sword?

  2006cites this paper
• Rational Design and Molecular Effects of a New Topoisomerase II Inhibitor , Azatoxin 1

  2006cites this paper
• Topoisomerase research of kinetoplastid parasite Leishmania, with special reference to development of therapeutics.

  2006cites this paper
• Maternal Diet and Infant Leukemia: The DNA Topoisomerase II Inhibitor Hypothesis: A Report from the Children's Oncology Group

  2005cites this paper
• A biflavonoid from Luxemburgia nobilis as inhibitor of DNA topoisomerases.

  2005cites this paper
• DNA topoisomerase I inhibitors from Rinorea anguifera.

  2005cites this paper
• Evaluation for Safety of Antioxidant Chemopreventive Agents

  2005cites this paper
• Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes.

  2005cites this paper
• Designing and Testing of an Effective Oil-in-Water Microemulsion Drug Delivery System for In Vivo Application

  2005cites this paper
• Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis.

  2005cites this paper
• Phytoestrogens and colorectal cancer prevention.

  2005cites this paper
• Endogenous estrogen status, but not genistein supplementation, modulates 7,12‐dimethylbenz[a]anthracene‐induced mutation in the liver cII gene of transgenic big blue rats

  2005cites this paper
• A Biflavonoid from Luxemburgia nobilis as inhibitor of DNA Topoisomerases

  2005cites this paper
• Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents

  2004cites this paper
• Granulocytic Differentiation of Leukemic Cells With t(9;11)(p22;q23) Induced by All-Trans-Retinoic Acid

  2004cites this paper
• The isoflavonoids genistein and quercetin activate different stress signaling pathways as shown by analysis of site-specific phosphorylation of ATM, p53 and histone H2AX.

  2004cites this paper
• Baicalin induces NAD(P)H:quinone reductase through the transactivation of AP-1 and NF-&kgr;B in Hepa 1c1c7 cells

  2004cites this paper
• AN ALTERNATIVE MODE OF ACTION OF ENDOCRINE-DISRUPTING CHEMICALS AND CHEMOPREVENTION

  2004cites this paper
• Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classes

  2004cites this paper
• Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro.

  2004cites this paper
• Topoisomerases of kinetoplastid parasites as potential chemotherapeutic targets.

  2004cites this paper
• Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity.

  2004cites this paper
• Design and development of novel DNA Topoisomerase inhibitors.

  2003cites this paper
• Conference on Food , Nutrition , and Cancer Isoflavone Genistein : Photoprotection and Clinical Implications in Dermatology 1 , 2

  2003cites this paper
• Genistein protects primary cortical neurons from iron-induced lipid peroxidation

  2003cites this paper
• Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity.

  2003cites this paper
• Isoflavone genistein: photoprotection and clinical implications in dermatology.

  2003cites this paper
• Cell‐transforming activity and mutagenicity of 5 phytoestrogens in cultured mammalian cells

  2003cites this paper
• Characterization of quercetin binding site on DNA gyrase.

  2003cites this paper
• Naringenin inhibits phosphoinositide 3-kinase activity and glucose uptake in 3T3-L1 adipocytes.

  2003cites this paper
• Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins.

  2003cites this paper
• Aurones: a subclass of flavones with promising biological potential.

  2003cites this paper
• Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer.

  2003cites this paper
• Reduction of genistein clastogenicity in Chinese hamster V79 cells by daidzein and other flavonoids.

  2003cites this paper
• Nonsteroidal anti‐inflammatory drug‐activated gene (NAG‐1) is induced by genistein through the expression of p53 in colorectal cancer cells

  2003cites this paper